Clinical Trial Update: A Multicentre, Randomised, Double-blind, Placebo-controlled Proof of Concept Study to Compare the Efficacy and Safety of r-hLIF (Emfilermin) for Improving Embryo Implantation Following in Vitro Fertilization (IVF) and Embryo Transfer (ET) in Women With Recurrent Implantation Failure [Phase 1, Phase 2]

View source ↗

Summary

This document reports on a multicentre, randomized, double-blind, placebo-controlled Phase 1/2 trial evaluating Emfilermin (r-hLIF) to improve embryo implantati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Emfilermin (recombinant human leukemia inhibitory factor)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility Implantation Failure | Phase 1, Phase 2 | Status: COMPLETED